Navigation Links
TrialNetworks Feasibility Survey™ App Gets ARIAD Pharmaceuticals Unprecedented 75% Response from Potential Clinical Trial Investigator Sites
Date:9/30/2013

ing the lives of cancer patients with breakthrough medicines.

Jeff Davis, Associate Director, Clinical Operations at ARIAD Pharmaceuticals, said, “ARIAD enjoys a strong collaboration with TrialNetworks and we were highly encouraged by the response we received using Feasibility Survey. Integrating these assessments into the rest of the platform ensures we realize the full benefits of TrialNetworks including more efficient processes, reduced time and cost, and a welcoming site experience. TrialNetworks technology makes it easy for sites to provide ARIAD with reliable information which we will use to make critical site selection decisions, and gives us clear visibility into and more control over global clinical operations than ever before.”

To prepare for the selection process, ARIAD sent the TrialNetworks Feasibility Survey to nearly 300 sites globally and received 225 responses – a huge accomplishment, says ARIAD Clinical Trial Manager Jay Pietrantonio: “The gold standard is to receive 50% of surveys back. To get 75% back is extremely impressive. The TrialNetworks Feasibility Survey app enabled ARIAD to meet our aggressive timeline for site selection by quickly identifying sites we are confident will enroll and exceed expectations in this pivotal trial.”

The TrialNetworks platform is the industry’s only Clinical Trial Optimization System proven to improve results from startup through closeout – including feasibility, site activation, patient recruitment and retention, site engagement and conduct – all from one centralized interface.

Eric Silberstein, CEO of TrialNetworks, said, “We are thrilled to partner with forward-thinking customers such as ARIAD who seek innovative solutions to make clinical operations more efficient. Equipping operations teams and sites with modern and efficient technology from feasibility through to closeout is becoming a critical success factor for sponsors and CROs.”

To discover how the TrialNetworks
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. TrialNetworks Customer to Present Results of Using Site Engagement Technology to Improve Study Operations and Patient Enrollment at Clinical Trial Optimization Conference
2. MannKind, Ariad Pharma, Ziopharm Oncology, Galena Biopharma, and Novavax Under StockCalls Microscope
3. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
4. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
5. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
6. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
7. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
8. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
9. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
10. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
11. Amylin Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... Oxford Finance LLC ("Oxford"), a specialty finance ... healthcare services companies, today announced the closing of a ... Inc., a diagnostic testing company focused on improving the ... and improved outcomes.  Proceeds of the loan will be ... of its products in the U.S. and ...
(Date:4/30/2015)... 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a ... medicine, today announced that it will release first quarter ... after the close of the U.S. financial markets. The ... Thursday, May 7, 2015 at 4:30 p.m. Eastern / ... corporate developments. For both "listen-only" participants and ...
(Date:4/30/2015)... Rancho Cordova, CA (PRWEB) April 30, 2015 ... today announced that Julie I. Morris has joined SureClinical’s ... Morris is an experienced biotech and technology executive with ... to large Fortune 500 companies. , Ms. Morris ... California-based ag biotech company. She was CFO of MBI ...
(Date:4/29/2015)... GUELPH, ON , April 29, 2015 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... twelve-month periods ended December 31, 2014. Biorem,s complete fiscal 2014 year-end financial ... FINANCIAL HIGHLIGHTS: 2014 , 2013 , 2014 ... 10,683 , 19,596 Gross profit 1,326 , ... 1,191 , 1,493 , 3,377 , ...
Breaking Biology Technology:Oxford Finance Provides $10 Million Debt Financing to Celula 2Asterias Biotherapeutics to Report First Quarter Results on May 7, 2015 2Asterias Biotherapeutics to Report First Quarter Results on May 7, 2015 3Julie I. Morris Joins SureClinical as Chief Financial Officer 2Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 2Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 3Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 4
... Rose Associates - Charleston, a leading retained executive ... promoted Bonnie R. Siegel as Partner of its ... information technology continues to be the fastest growing ... Bonnie will continue to focus on placing key ...
... This release is available in German . ... of DNA nanotechnology. This new discipline, which combines biology, physics, ... the natural DNA-strains, capacity for self assembly. Smileys or small ... meter) were created from DNA in a drop of water. ...
... Corporation, a leading developer of minimally invasive optical coherence ... has installed the first of its OCT Imaging Systems ... in Galveston, Texas. This first system sale ... Dr. Massoud Motamedi, Director, Center for Biomedical Engineering at ...
Cached Biology Technology:Sanford Rose Associates - Charleston Promotes Bonnie Siegel to Partner 2The world's smallest wedding rings 2Tomophase Announces First Sale of Its OCT Imaging System (OCTIS™) for Research Use to the University of Texas 2
(Date:3/31/2015)... YORK , March 31, 2015  Elephant Talk ... "Company"), a global provider of Software Defined Network Architecture ... today announced total revenue of approximately $20.4 million for ... a restated $19.5 million for the year ended December ... calendar 2014, the Company had completed its multi-year transition ...
(Date:3/24/2015)... , Mar. 24, 2015 Research and Markets ( ... Voice Biometrics - Global Strategic Business Report" report to their ... and Voice Biometrics in US$ Thousands by the following Segments: Face ... the US, Canada , Japan ... Middle East & Africa ...
(Date:3/23/2015)... 2015  In the 2014 fiscal year, irs.gov recorded ... This figure accounts for a fraction of the estimated ... Report, exceeds $11 billion globally. The polygraph has traditionally ... has occurred. Investor Mark Saint Juste along ... Paolella partnered to administer the test in a ...
Breaking Biology News(10 mins):Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... at Linkping University previously developed ion transistors for transport ... biomolecules. Tybrandt has now succeeded in combining both transistor ... traditional silicon-based electronics. An advantage of chemical ... substances with various functions. This means that we now ...
... New research from Lund University in Sweden reveals the value ... dung beetles and the way their protective forewings actually function. ... beetles to lift off from the ground albeit at ... hardened structures which protect the insect,s flying wings and body. ...
... borders with colourful bedding plants, scientists at the Universities of ... attractive to bees rather than humans. Published today in the ... reveals that Velcro-like cells on plant petals play a crucial ... wind gets up., The study focuses on special cells found ...
Cached Biology News:Flapping protective wings increase lift 2Blowing in the wind: How hidden flower features are crucial for bees 2
... For knockdown of all human, ... siRNAs , Genomewide, predesigned siRNAs ... RNAi , Ready-to-use, convenient matching ... RT-PCR Cost-effective RNAi and ...
... Rapid-Screen cDNA Library Panels were designed for ... sets of PCRs to identify the desired ... performed in a 96-well "Master Plate," where ... clones. Having identified the positive well(s) by ...
... CEQ 8800 Genetic Analysis System, which processes ... This automated system adds a higher level of ... CEQ 8800, part of Beckman Coulters new GenomeLab ... link with the Biomek series liquid handers, for ...
... for proteomic scale kinase profiling, quantitative measurement ... research built on the flexible and powerful ... are available as part of our comprehensive ... Probe Content Our standard ...
Biology Products: